CRISPR Therapeutics (CRSP) PT Lowered to $100 at Evercore ISI

February 17, 2022 6:26 AM EST Send to a Friend
Evercore ISI analyst Liisa Bayko ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login